Literature DB >> 6994088

Effect of nosiheptide as a feed additive in chicks on the quantity, duration, prevalence of excretion, and resistance to antibacterial agents of Salmonella typhimurium; on the proportion of Escherichia coli and other coliforms resistant to antibacterial agents; and on their degree and spectrum of resistance.

F Benazet, J R Cartier.   

Abstract

In the first experiment two groups (B and D) each of ten, 15-day-old chicks were fed for 33 days a diet supplemented with nosiheptide (20 g/t) and 2 groups (A and C) of 10 each a diet without medication. Groups A and B were inoculated with Salmonella typhimurium, var. copenhagen (variant resistant to nalidixic acid of the strain DVR 101) 5 days after treatment was started. At intervals of 2, 4, 6, 8, 10, 12, 14, 21, and 28 days postinoculation the following data were collected: the number of salmonella excreted per gram of feces, their duration and prevalence of excretion, and the proportion of salmonella resistant to 9 antibacterial agents commonly used in human and veterinary medicine, as well as their degree and spectrum of resistance. In the second experiment two groups of 10 chicks each were fed either a basal diet (control group) or a diet supplemented with nosiheptide at 20 g/t (treated group). Immediately before and at the end of treatment, the proportions of fecal coliforms, particularly E. coli, which were resistant to 11 commonly used antibacterial agents, and their degree and spectrum of resistance were determined in the 2 groups of chicks. All the strains isolated before treatment started were E. coli sensitive to the 11 antibacterial agents. The strains isolated at the end of treatment were coliforms otherthan E. coli (40% in the control group, 32% in the treated group) and E. coli (60 and 68%, respectively). Coliforms other than E. coli were, as is usual, resistant to ampicillin and sensitive to the other antibacterial agents. The E. coli strains were either sensitive to all the antibacterial agents or resistant to tetracycline and furazolidone (51.8% in the control group, 34.1% in the treated group), or resistant to furazolidone alone (3.7% in the control group, 5.8% in the treated group). In both experiments these determinations showed no appreciable differences between treated and untreated chicks.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6994088     DOI: 10.3382/ps.0591405

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  7 in total

Review 1.  Thiopeptides: antibiotics with unique chemical structures and diverse biological activities.

Authors:  Derek C K Chan; Lori L Burrows
Journal:  J Antibiot (Tokyo)       Date:  2020-12-21       Impact factor: 2.649

2.  Mutagenesis of NosM Leader Peptide Reveals Important Elements in Nosiheptide Biosynthesis.

Authors:  Liang Jin; Xuri Wu; Yanjiu Xue; Yue Jin; Shuzhen Wang; Yijun Chen
Journal:  Appl Environ Microbiol       Date:  2017-02-01       Impact factor: 4.792

3.  Factors influencing salmonella shedding in broiler chickens.

Authors:  R H Gustafson; J D Kobland
Journal:  J Hyg (Lond)       Date:  1984-06

4.  Nosiheptide biosynthesis featuring a unique indole side ring formation on the characteristic thiopeptide framework.

Authors:  Yi Yu; Lian Duan; Qi Zhang; Rijing Liao; Ying Ding; Haixue Pan; Evelyn Wendt-Pienkowski; Gongli Tang; Ben Shen; Wen Liu
Journal:  ACS Chem Biol       Date:  2009-10-16       Impact factor: 5.100

Review 5.  YcaO-Dependent Posttranslational Amide Activation: Biosynthesis, Structure, and Function.

Authors:  Brandon J Burkhart; Christopher J Schwalen; Greg Mann; James H Naismith; Douglas A Mitchell
Journal:  Chem Rev       Date:  2017-03-03       Impact factor: 60.622

6.  In vitro and intracellular inhibitory activities of nosiheptide against Mycobacterium abscessus.

Authors:  Rui Zhu; Xia Yu; Tingting Zhang; Yaoyao Kong; Fen Wang; Junnan Jia; Yi Xue; Hairong Huang
Journal:  Front Microbiol       Date:  2022-07-26       Impact factor: 6.064

7.  Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus.

Authors:  Nina M Haste; Wdee Thienphrapa; Dan N Tran; Sandra Loesgen; Peng Sun; Sang-Jip Nam; Paul R Jensen; William Fenical; George Sakoulas; Victor Nizet; Mary E Hensler
Journal:  J Antibiot (Tokyo)       Date:  2012-10-10       Impact factor: 2.649

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.